Dr. Steven Kaplan is Director of the Men's Wellness Program, Mount Sinai Health System and Professor, Icahn School of Medicine at Mount Sinai. He is an internationally renowned authority and one of the primary thought leaders in the study of benign prostatic diseases, the association of metabolic factors with voiding dysfunction, and female urology, with symptoms related to both benign prostate enlargement and bladder function.
Dr. Kaplan is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He is an internationally recognized authority and one of the primary thought leaders in the study of benign diseases of the prostate, the association of metabolic factors and voiding dysfunction and female urology. He has over 1000 publications including 600 peer reviewed and 570 peer reviewed invited articles, and 90 book chapters and non – peered reviewed articles. His landmark study, published in JAMA in 2006, changed the way medications are used in the treatment of men with symptoms related to both benign prostate enlargement and bladder dysfunction. He has made over 340 presentations in more than 35 countries. He is the co - author of five books and is on the Editorial Board of numerous journals including Urology, Journal of Urology, and Urology Times.
Dr. Kaplan is a member of more than 30 professional organizations, been awarded 5 NIH grants and has received over 13 million dollars in research funding. He serves as both member and / or Chair of numerous study sections for the NIH and more recently, he chaired the NIDDK Prostate Strategic Planning Committee and currently Chairs the AUA Research Committee on Advocacy. He also has served on the American Urologic Association Guidelines Panel for BPH. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation.
Dr. Kaplan joined Mount Sinai from Weill Cornell Medical College, where he held the tenured position of E. Darracott Vaughan, Jr. Professor of Urology as well as Director of the Iris Cantor Men’s Health Center. In that position, he was responsible for the development of a new discipline within Urology, Integrated Men’s Health. Over his tenure at Weill Cornell Medical College, he was actively engaged with teaching and supervising both residents and fellows and was the Director of the Fellowship Program in Male and Female Voiding Dysfunction. Prior to this, he held the tenured position of Given Foundation Professor of Urology at Columbia University and was the Vice Chairman and Program Director.
Dr. Kaplan graduated from Mount Sinai School of Medicine in 1982 and was elected to the AOA Honor Society. Dr. Kaplan’s postgraduate training included an internship and residency in the Department of Surgery at Mount Sinai Hospital as well as a residency in Urology at the Squier Urologic Clinic, Columbia University. He was an American Urologic Association Scholar between 1988 - 1990 that focused on identifying molecular markers and urodynamic parameters that herald bladder and prostate dysfunction.
Urologists are the “domain experts” in any medical setting for the choice, insertion, and maintenance of a Foley catheter for their own patients or as consultants in all other healthcare settings. As such, Urologists can be an important resource to physicians and other healthcare providers, educating them regarding the rationale for and use of the FIZE kUO™ device, the natural choice to better manage patients with an indwelling Foley catheter. Furthermore, Urologists can play a leading role in performing and publishing or presenting clinical research studies of the kUO™. 
